Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $46.8 million.

  • MDxHealth's Cash & Current Investments fell 502.11% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year decrease of 502.11%. This contributed to the annual value of $22.4 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, MDxHealth's Cash & Current Investments stood at $46.8 million, which was down 502.11% from $46.8 million recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Cash & Current Investments peaked at $65.7 million during Q1 2025, and registered a low of $14.5 million during Q1 2024.
  • Its 5-year average for Cash & Current Investments is $39.1 million, with a median of $43.4 million in 2022.
  • Per our database at Business Quant, MDxHealth's Cash & Current Investments crashed by 7349.82% in 2022 and then skyrocketed by 35309.78% in 2025.
  • Over the past 5 years, MDxHealth's Cash & Current Investments (Quarter) stood at $58.5 million in 2021, then tumbled by 73.5% to $15.5 million in 2022, then soared by 44.36% to $22.4 million in 2023, then skyrocketed by 109.11% to $46.8 million in 2024, then changed by 0.0% to $46.8 million in 2025.
  • Its Cash & Current Investments was $46.8 million in Q3 2025, compared to $46.8 million in Q2 2025 and $65.7 million in Q1 2025.